Visceral fat thickness in overweight men correlates with alterations in serum fatty acid composition

Clinica Chimica Acta

Volumn 398, Issue 1-2, 2008, Pages 57-62

  Kishino, Tomonori ^a   Watanabe, Keiko ^b   Urata, Tsuyoshi ^b   Takano, Maiko ^b   Uemura, Takamoto ^a   Nishikawa, Kaori ^a   Mine, Yoshitake ^a   Matsumoto, Motoko ^a   Ohtsuka, Kouki ^a   Ohnishi, Hiroaki ^a   Mori, Hideaki ^a   Takahashi, Shin'ichi ^a   Ishida, Hitoshi ^a   Watanabe, Takashi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

Fatty acid composition; Metabolic syndrome; Overweight; Ultrasonography; Visceral fat

Indexed keywords

ACYL COENZYME A DESATURASE; FATTY ACID; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; PALMITIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; JAPANESE; LIPID COMPOSITION; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL;

ADIPOSITY; ADULT; AGED; ALCOHOL DRINKING; BODY MASS INDEX; CHROMATOGRAPHY, GAS; DIABETES MELLITUS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FLAME IONIZATION; HUMANS; HYPERTENSION; JAPAN; LINOLEIC ACID; LINOLEOYL-COA DESATURASE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; PALMITIC ACID; SMOKING; WAIST CIRCUMFERENCE;

EID: 54149104416     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.08.010     Document Type: Article

References (47)

1. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. Fujioka S., Matsuzawa Y., Tokunaga K., and Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36 (1987) 54-59
3. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149 (1989) 1514-1520
4. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
5. Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44 (1993) 121-131
6. Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 13 (1997) 3-13
7. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., American Heart Association;, National Heart, Lung, and and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
8. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
9. Vessby B., Aro A., Skarfors E., Berglund L., Salminen I., and Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43 (1994) 1353-1357
10. Vessby B., Tengblad S., and Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37 (1994) 1044-1050
11. Ma J., Folsom A.R., Lewis L., and Eckfeldt J.H. Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 65 (1997) 551-559
12. Zheng Z.J., Folsom A.R., Ma J., Arnett D.K., McGovern P.G., and Eckfeldt J.H. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 150 (1999) 492-500
13. Grimsgaard S., Bønaa K.H., Jacobsen B.K., and Bjerve K.S. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 34 (1999) 478-483
14. Fernández-Real J.M., Vayreda M., Casamitjana R., Gonzalez-Huix F., and Ricart W. Circulating granulocyte-macrophage colony-stimulating factor and serum fatty acid composition in men and women. Metabolism 50 (2001) 1479-1483
15. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 83 (2000) S91-S96
16. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., and Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967 (2002) 183-195
17. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 14 (2003) 15-19
18. Warensjö E., Risérus U., and Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48 (2005) 1999-2005
19. Warensjö E., Sundström J., Lind L., and Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 84 (2006) 442-448
20. Klein-Platat C., Drai J., Oujaa M., Schlienger J.L., and Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82 (2005) 1178-1184
21. Hubert H.B., Feinleib M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968-977
22. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
23. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
24. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 94 (2005) 794-809 (in Japanese)
25. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
26. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
27. McNeely M.J., Boyko E.J., Shofer J.B., Newell-Morris L., Leonetti D.L., and Fujimoto W.Y. Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. Am J Clin Nutr 74 (2001) 101-107
28. Enkhmaa B., Shiwaku K., Anuurad E., et al. Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chim Acta 352 (2005) 105-113
29. Wirth A., and Steinmetz B. Gender differences in changes in subcutaneous and intra-abdominal fat during weight reduction: an ultrasound study. Obes Res 6 (1998) 393-399
30. Armellini F., Zamboni M., Rigo L., et al. The contribution of sonography to the measurement of intra-abdominal fat. J Clin Ultrasound 18 (1990) 563-567
31. Leite C.C., Wajchenberg B.L., Radominski R., Matsuda D., Cerri G.G., and Halpern A. Intra-abdominal thickness by ultrasonography to predict risk factors for cardiovascular disease and its correlation with anthropometric measurements. Metabolism 51 (2002) 1034-1040
32. Hirooka M., Kumagi T., Kurose K., et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med 44 (2005) 794-799
33. Sabir N., Sermez Y., Kazil S., and Zencir M. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound 14 (2001) 121-128
34. Ribeiro-Filho F.F., Faria A.N., Azjen S., Zanella M.T., and Ferreira S.R. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res 11 (2003) 1488-1494
35. Sabir N., Pakdemirli E., Sermez Y., Zencir M., and Kazil S. Sonographic assessment of changes in thickness of different abdominal fat layers in response to diet in obese women. J Clin Ultrasound 31 (2003) 26-30
36. Ma J., Folsom A.R., Lewis L.A., and Eckfeldt J.H. Expression of plasma fatty acid data in studies of cardiovascular disease risk: concentration or percentage?. Clin Chem 39 (1993) 2527-2529
37. Sul H.S., and Wang D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 18 (1998) 331-351
38. El Hafidi M., Cuéllar A., Ramírez J., and Baños G. Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Delta9 and Delta5-desaturase activities. J Nutr Biochem 12 (2001) 396-403
39. Bergouignan A., Schoeller D.A., Normand S., et al. Effect of physical inactivity on the oxidation of saturated and monounsaturated dietary fatty acids: results of a randomized trial. PLoS Clin Trials 1 (2006) e27
40. Mougios V., Kotzamanidis C., Koutsari C., and Atsopardis S. Exercise-induced changes in the concentration of individual fatty acids and triacylglycerols of human plasma. Metabolism 44 (1995) 681-688
41. Levine J.A., Jensen M.D., Eberhardt N.L., and O'Brien T. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest 101 (1998) 1557-1564
42. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
43. Fernández-Real J.M., Vendrell J., and Ricart W. Circulating adiponectin and plasma fatty acid profile. Clin Chem 51 (2005) 603-609
44. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
45. Hernandez-Morante J.J., Milagro F.I., Larque E., et al. Relationship among adiponectin, adiponectin gene expression and fatty acids composition in morbidly obese patients. Obes Surg 17 (2007) 516-524
46. Hammond L.E., Gallagher P.A., Wang S., et al. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 22 (2002) 8204-8214
47. Borkman M., Storlien L.H., Pan D.A., Jenkins A.B., Chisholm D.J., and Campbell L.V. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328 (1993) 238-244